Vol. 33 (6) 2012 Neuro endocrinology letters

Natalizumab in the treatment of pediatric multiple sclerosis.

: Pediatric cerebrospinal multiple sclerosis (MS) constitutes about 2-5% of all MS cases. The International Pediatric MS Study Group (IPMSSG) applies diagnostic criteria for adults to MS in childhood and adolescence. Recent publications highlight an increasing number of MS in children resistant to the first-line treatment, i.e. disease .....